Arvid Rongve

Professor

University of Bergen
Country flagNorway

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (4)

Year:

2026

Alzheimer’s disease (AD) is the most common cause of dementia, with global case numbers projected to reach 153 million in 2050 1 . AD is highly heritable, with twin-based heritability estimates of 60-80% 2 . While 1,200 causal loci are predicted to exist for AD 3 , approximately 80 have been associated with AD in two recent studies 4,5 , suggesting that many loci remain to be discovered 6 . Here, we analyzed data from 183,620 AD cases and 2.6 million controls from diverse ancestries, identifying 118 loci in a multi-ancestry analysis and 9 additional loci in ancestry-specific analyses, 48 of which are new. We identified new AD risk genes, prioritized potential drug targets, and identified microglia and, for the first time, several neuronal cell types enriched for AD-associated genetic risk. Moreover, we improved polygenic prediction and estimated a single-nucleotide polymorphism (SNP) heritability of 19%. Together, our findings offer insights into the genetic architecture and potential pathobiology of AD, as well as specific targets for future drug development research.

Year:

2025

Among the more than 90 identified genetic risk loci for late-onset Alzheimer’s disease (AD) and related dementias, the apolipoprotein E gene ( APOE ) ɛ2/ɛ3/ɛ4 polymorphisms remains the longstanding benchmark for genetic disease risk with a consistently large effect across studies 1–10 . Despite this massive signal, the exact mechanisms for how ɛ4 increases and for how ɛ2 decreases dementia risk is not well-understood. Importantly, recent trials of anti-amyloid therapies suggest less efficacy and higher risks of severe side effects in ε4 carriers 11–13 , hampering the treatment of those with the highest unmet need. To improve our understanding of the genetic architecture of AD in the context of its main genetic driver, we performed genome-wide association studies (GWASs) stratified by ε4 and ε2 carrier status. Such insights may help to understand and overcome side effects, to impact clinical trial enrolment strategies, and to create the scientific basis for targeted mechanism-driven therapies in neurodegenerative diseases.

Year:

2025

Background and objectives Detecting Alzheimer’s disease (AD) biological and clinical changes is crucial for early diagnostic and therapeutic interventions. Here we investigate the relationship between clinical severity and levels of phosphorylated tau, focusing on plasma biomarkers, in preclinical and prodromal AD. Methods In this study (n=621), we examined two independent cohorts consisting of preclinical and prodromal AD. Cohort-1 included 431 participants classified as either cognitively normal (CN) or mild cognitive impaired (MCI) with normal or abnormal cerebrospinal fluid (CSF) Aβ42/40 ratio (A) and p-tau181 (T) [CN A-/T-, n=169; A+/T-, CN=26; MCI=24; A+/T+, CN=40; MCI=105; CN=34; MCI=33]. A total of n=418 of the participants had longitudinal assessments of verbal memory up to 9.67 years from baseline. Cohort-2 included 190 participants in whom amyloid status was determined using Aβ positron emission tomography (PET) [Aβ- CN= 118; Aβ+ CN= 49; Aβ+ MCI= 21]. Results In cohort-1, plasma p-tau217 showed a moderate correlation with its corresponding CSF biomarker (rho=0.65, p<.001) and high accuracy identifying Aβ+ participants (AUC: 0.85). Diagnostic accuracy of plasma p-tau217 was significantly greater for MCI Aβ+ (AUC: 0.89) versus CN Aβ+ (AUC: 0.79, p<.05) and for A+/T+ (AUC: 0.88) versus A+/T- (AUC: 0.78, p<.05). P-tau181 and p-tau231 showed significantly weaker CSF-plasma correlations (rho= 0.47, and rho=0.32, p<.001, respectively) and levels were not as tightly associated with cognitive status in the Aβ+ group. While all the CSF p-tau markers were associated to future cognitive deterioration, p-tau217 was the only plasma biomarker associated with future memory decline (β=0.05, p<0.05). In cohort 1 and 2, plasma p-tau217 showed significantly higher concentrations in MCI Aβ+ as compared to CN Aβ+. Furthermore, plasma p-tau217 demonstrates similar biomarker elevations when compared to CN Aβ- controls in both cohorts. Discussion Our findings indicate that, unlike p-tau181 and p-tau231, plasma p-tau217 consistently aligns with cognitive status in Aβ+ individuals and more closely reflects CSF biomarker abnormalities, potentially reducing discrepancies between clinical and biochemical findings. The associations of plasma p-tau217 with baseline and future cognitive decline make it a valuable complement to clinical evaluations in preclinical and prodromal AD, especially when CSF analysis or PET are not feasible.

Year:

2024

Collaborators (69)

Ruth Frikke-Schmidt

Professor, Chief Physician, MD PhD DMSc

-

DENMARK
View details

Pau Pastor

Institut Català de la Salut

SPAIN
View details

Eloy Rodriguez-Rodríguez

Instituto de Investigación Marqués de Valdecilla

SPAIN
View details

innocenzo rainero

University of Turin

ITALY
View details

Agustín Ruiz Laza

Director of the Biology Core

University of Texas Health Science Center at San Antonio

UNITED STATES
View details

Harro Seelaar

Neurologist

Erasmus MC

NETHERLANDS
View details

Paul O'Reilly

Associate Professor

Icahn School of Medicine at Mount Sinai

UNITED STATES
View details

Philippe Amouyel

Full Professor

Centre Hospitalier Régional Universitaire de Lille

FRANCE
View details

Jesper Qvist Thomassen

Senior Scientist

Rigshospitalet

DENMARK
View details

Clive Ballard

Pro-Vice Chancellor and Executive Dean

University of Exeter

UNITED KINGDOM
View details

Henne Holstege

Professor

KU Leuven

BELGIUM
View details

Marco Spallazzi

Adjunt professor

University of Parma

ITALY
View details

Benedetta Nacmias

University of Florence

ITALY
View details

Lucilla Parnetti

Professor of Neurology

University of Perugia

ITALY
View details

Caroline Jonson

University of California, San Francisco

UNITED STATES
View details

Pieter Jelle Visser

Karolinska Institutet

SWEDEN
View details

Jordi Pérez-Tur

Coordinador Adjunto al Área Global Vida

Agencia Estatal Consejo Superior de Investigaciones Científicas

SPAIN
View details

Patrizia Mecocci

Director

Karolinska Institutet

SWEDEN
View details

Caroline Graff

Professor,MD PhD

Karolinska Institutet

SWEDEN
View details

Henna Martiskainen

University of Eastern Finland

FINLAND
View details

Amy Kit Yu Fu

Research Professor

The Hong Kong University of Science and Technology

HONG KONG
View details

Jean-Charles Lambert

Head of research unit

INSERM

FRANCE
View details

Betty Tijms

Senior researcher

VU medisch centrum

NETHERLANDS
View details

Nancy Yuk-Yu Ip

The Morningside Professor of Life Science

The Hong Kong University of Science and Technology

HONG KONG
View details

Katja Scheffler

Associate Professor

Norwegian University of Science and Technology

NORWAY
View details

Geert Jan Biessels

Professor of Neurology

University Medical Center Groningen

NETHERLANDS
View details

Sara Hägg

Senior Researcher

Karolinska Institutet

SWEDEN
View details

Takeshi Ikeuchi

Professor

Brain Research Institute, Niigata University

JAPAN
View details

Mohsen Ghanbari

Associate professor

Erasmus MC

NETHERLANDS
View details

Geir Selbaek

Professor

University of Oslo

NORWAY
View details

Lasse Pihlstrøm

Professor

University of Oslo

NORWAY
View details

Byron Creese

Senior Lecturer & Director of Research

Brunel University London

UNITED KINGDOM
View details

Chandra A Reynolds

Professor

University of Colorado Boulder

UNITED STATES
View details

Pablo Mir

-

SPAIN
View details

Tormod Fladby

Professor ll of Neurology

University of Oslo

NORWAY
View details

Jens Hjerling Leffler

Karolinska Institutet

SWEDEN
View details

Thomas Truelsen

University of Copenhagen

DENMARK
View details

Srdjan Djurovic

Senior Researcher

University of Oslo

NORWAY
View details

Christian Erikstrup

Chair Professor

Aarhus University

DENMARK
View details

Sami Heikkinen

Research Director

University of Eastern Finland

FINLAND
View details

Najaf Amin

Associate Professor

University of Oxford

UNITED KINGDOM
View details

Wiesje van der Flier

Scientific director

VU medisch centrum

NETHERLANDS
View details

Peter Holmans

Professor of Biostatistics and Genetic Epidemiology

Cardiff University

UNITED KINGDOM
View details

Alessandro Serretti

Docenti di ruolo di IIa fascia

Università degli Studi di Enna Kore

ITALY
View details

Bjørn-Eivind Kirsebom

UiT The Arctic University of Norway

NORWAY
View details

Dan Rujescu

Head of Clinical Division of General Psychiatry

Medical University of Vienna

AUSTRIA
View details

Alessio Squassina

Dalhousie University

CANADA
View details

Carole Dufouil

Director of research

INSERM

FRANCE
View details

Martin Ingelsson

Specialist

Uppsala University Hospital

SWEDEN
View details

Gael Nicolas

PUPH

University of Rouen

FRANCE
View details

D.P. Wightman

University of Amsterdam

NETHERLANDS
View details

Anssi Lipponen

University of Eastern Finland

FINLAND
View details

Patrick Kehoe

Academic , Gestetner Professor of Translational Dementia Research

University of Bristol

UNITED KINGDOM
View details

Thomas Folkmann Hansen

Professor

Technical University of Denmark

DENMARK
View details

Fernando Gonzalez-Ortiz

University of Gothenburg

SWEDEN
View details

INGVILD SALTVEDT

Professor

Norwegian University of Science and Technology

NORWAY
View details

Morten Fjeld

Professor

University of Bergen

SWEDEN
View details

Jian Zeng

The University of Queensland

AUSTRALIA
View details

Dag Aarsland

Professor and Head of Department

King’s College London

UNITED KINGDOM
View details

Daniela Galimberti

Associate Professor

Università degli Studi di Torino

ITALY
View details

Ole A. Andreassen

Oslo University Hospital

NORWAY
View details

Lucio Tremolizzo

Associate Professor of Neurology

University of Milano-Bicocca

ITALY
View details

Valentina Escott-Price

Professor

Cardiff University

UNITED KINGDOM
View details

Ville Leinonen

Professor

University of Eastern Finland

FINLAND
View details

Rebecca Sims

Senior Research Fellow

Cardiff University

UNITED KINGDOM
View details

Barbara Borroni

Docenti di ruolo di IIa fascia

University of Brescia

ITALY
View details

Jose Luis Royo

University of Malaga

SPAIN
View details

Mikko Hiltunen

University of Eastern Finland

FINLAND
View details

Frank J. Wolters

Associate professor

Erasmus University Rotterdam

NETHERLANDS
View details